Amanote Research

Amanote Research

    RegisterSign In

The Role of Mutant P53 Protein in Breast Cancer.

doi 10.21236/ada344920
Full Text
Open PDF
Abstract

Available in full text

Date

September 1, 1997

Authors
Carol L. Prives
Publisher

Defense Technical Information Center


Related search

PRIMA-1 Inhibits Growth of Breast Cancer Cells by Re-Activating Mutant P53 Protein

International Journal of Oncology
Cancer ResearchOncology
2009English

ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells

Oncotarget
Oncology
2016English

Mutant P53 Protein, Master Regulator of Human Malignancies: A Report on the Fifth Mutant P53 Workshop

Cell Death and Differentiation
Cell BiologyMolecular Biology
2011English

Multifunctional Compounds for Activation of the P53 Y220C Mutant in Cancer

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2018English

Cancer Therapeutic Approach Based on Conformational Stabilization of Mutant P53 Protein by Small Peptides

Oncotarget
Oncology
2016English

A Novel Mutant P53 Binding Partner BAG5 Stabilizes Mutant P53 and Promotes Mutant P53 GOFs in Tumorigenesis

Cell Discovery
BiochemistryGeneticsCell BiologyMolecular Biology
2016English

Cancer Therapeutic Targeting Using Mutant–p53-Specific siRNAs

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Genomic Instability in Mutant P53 Cancer Cells Upon Entotic Engulfment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Alpelisib Extends PFS in PIK3CA-Mutant Breast Cancer

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy